Close

Voyager Therapeutics, Genzyme (SNY) Enter CNS Disorder Therapy Collaboration

February 11, 2015 8:57 AM EST Send to a Friend
Voyager Therapeutics and Genzyme, a Sanofi company (NYSE: SNY) announced a major strategic collaboration to discover, develop and commercialize ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login